The Company will present certain information regarding its vaccine candidates targeting COVID-19 (the “Presentation”) at the GEN (Genetic and Engineering News) “NYC Builds Bio+ Vanquishing the Virus” panel on Tuesday, May 19. The Presentation, which may contain nonpublic information, is filed as Exhibit 99.01 hereto and incorporated herein by reference.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.